Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable (2023) Bauer M, Hildebrand L, Rosahl MC, Erber R, Schnellhardt S, Büttner-Herold M, Putz F, et al. Journal article Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies (2023) Weissmann T, Rückert M, Putz F, Donaubauer AJ, Hecht M, Schnellhardt S, Schubert P, et al. Journal article, Review article The Emerging Evidence Supporting Integration of Deep Regional Hyperthermia With Chemoradiation in Bladder Cancer (2023) Ott O, Gaipl U, Lamrani A, Fietkau R Journal article, Review article Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells (2022) Stoll E, Hader M, Rückert M, Weissmann T, Lettmaier S, Putz F, Hecht M, et al. Journal article Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines (2022) Schatz J, Ladinig A, Fietkau R, Putz F, Gaipl U, Frey B, Derer A Journal article Effect of Citrate- and Gold-Stabilized Superparamagnetic Iron Oxide Nanoparticles on Head and Neck Tumor Cell Lines during Combination Therapy with Ionizing Radiation (2022) Schreiber C, Franzen T, Hildebrand L, Stein R, Friedrich B, Tietze R, Fietkau R, Distel L Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2022) Jost T, Faulhaber EM, Symank JA, Scheper J, Bürkel F, Fietkau R, Hecht M, Distel L Conference contribution, Abstract of a poster Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2022) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller SK, Traxdorf M, et al. Conference contribution Automating implant reconstruction in interstitial brachytherapy of the breast: A hybrid approach combining electromagnetic tracking and image segmentation (2022) Dürrbeck C, Sauer B, Lotter M, Kreppner S, Strnad V, Fietkau R, Bert C Journal article